First, confirm youre on a therapeutic dose ( 1.7 mg weekly) for at least 12 weeks
The Specialist Pharmacy Service (SPS) advises that if a patient is already taking a DPP-4 inhibitor and requires treatment intensification, switching to a GLP-1 receptor agonist (rather than adding it) is the preferred approach
However, the ongoing treatment costs for these medications raise concerns about the sustainability of their widespread use in the healthcare system, especially given the risk of weight regain without continued use
Obesity GLP-1 Market Value Chain Analysis Who are the Major Players in the Global Obesity GLP-1 Market
Use the peptide cost calculator to estimate total treatment costs across different durations and dose levels
Success depends on many factors, including weight history, metabolic risk, appetite, activity, nutrition, sleep, stress, medical conditions, and medication history